A newly developed oral heparin derivative for deep vein thrombosis: Non-human primate study
- 1 November 2007
- journal article
- research article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 123 (2), 155-163
- https://doi.org/10.1016/j.jconrel.2007.08.007
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Oral bioavailability of a low molecular weight heparin using a polymeric delivery systemJournal of Controlled Release, 2006
- Anticoagulant Activity of Heparin Following Oral Administration of Heparin‐Loaded Microparticles in RabbitsJournal of Pharmaceutical Sciences, 2002
- Oral Heparin Prevents Neointimal Hyperplasia After Arterial InjuryCirculation, 2001
- Guide to Anticoagulant Therapy: HeparinCirculation, 2001
- Orally administered unfractionated heparin with carrier agent is therapeutic for deep venous thrombosis.Circulation, 2000
- Oral Delivery of Anticoagulant Doses of HeparinCirculation, 1998
- Antithrombotic Therapy for Venous Thromboembolic DiseaseChest, 1995
- Epidemiology and natural history of venous thromboembolismProgress in Cardiovascular Diseases, 1994
- Adjusted Subcutaneous Heparin versus Warfarin Sodium in the Long-Term Treatment of Venous ThrombosisNew England Journal of Medicine, 1982
- Warfarin Sodium versus Low-Dose Heparin in the Long-Term Treatment of Venous ThrombosisNew England Journal of Medicine, 1979